Hemorrhage control in the battlefield: role of new hemostatic agents

Mil Med. 2005 Jan;170(1):63-9. doi: 10.7205/milmed.170.1.63.

Abstract

Uncontrolled hemorrhage is the leading cause of preventable combat-related deaths. The vast majority of these deaths occur in the field before the injured can be transported to a treatment facility. Early control of hemorrhage remains the most effective strategy for treating combat casualties. A number of hemostatic agents have recently been deployed to the warfront that can be used to arrest bleeding before surgical control of the source. The purpose of this article is to summarize the background information regarding these hemostatic agents, indications and rationale for their use, and characteristics of these products that may impact effectiveness.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Acetylglucosamine / therapeutic use
  • Blood Coagulation / drug effects
  • Fibrin Tissue Adhesive / therapeutic use
  • Hemorrhage / drug therapy*
  • Hemorrhage / prevention & control
  • Hemostatics / classification
  • Hemostatics / therapeutic use*
  • Humans
  • Military Medicine / methods*
  • Warfare*
  • Wounds and Injuries / physiopathology*
  • Zeolites / therapeutic use

Substances

  • Fibrin Tissue Adhesive
  • Hemostatics
  • poly-N-acetyl glucosamine
  • Zeolites
  • Acetylglucosamine